Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Keith Hawton a Centre for
Suicide Research, University Department of Psychiatry, Warneford
Hospital, Oxford OX3 7JX, b ICRF/NHS Centre for Statistics in Medicine, Institute of
Health Sciences, Oxford OX3 7LF, c School of Psychiatry and Behavioural
Sciences, Department of Psychiatry, University of Manchester,
Withington Hospital, Manchester M20 8LR, d Department of Social Medicine, University of Bristol,
Bristol BS8 2PR
Correspondence to: K Hawton keith.hawton{at}psych.ox.ac.uk
Objective:
To evaluate the effects on suicidal
behaviour of legislation limiting the size of packs of paracetamol and
salicylates sold over the counter.
What is already known on this topic
What this study adds
Design:
Before and after study.
Setting:
UK population, with detailed monitoring
of data from five liver units and seven general hospitals, between September 1996 and September 1999.
Subjects:
People who died by suicidal or
accidental overdose with paracetamol or salicylates or who died of
undetermined causes; patients admitted to liver units with hepatic
paracetamol poisoning; patients presenting to general hospitals with
self poisoning after taking paracetamol or salicylates.
Main outcome measures:
Mortality from paracetamol
or salicylate overdose; numbers of patients referred to liver units or
listed for liver transplant; numbers of transplantations; numbers of
overdoses and tablets taken; blood concentrations of the drugs;
prothrombin times; sales to pharmacies and other outlets of paracetamol
and salicylates.
Results:
Numbers of tablets per pack of
paracetamol and salicylates decreased markedly in the year after the
change in legislation on 16 September 1998. The annual number of deaths from paracetamol poisoning decreased by 21% (95% confidence interval 5% to 34%) and the number from salicylates decreased by 48% (11% to
70%). Liver transplant rates after paracetamol poisoning decreased by
66% (55% to 74%). The rate of non-fatal self poisoning with paracetamol in any form decreased by 11% (5% to 16%), mainly because of a 15% (8% to 21%) reduction in overdoses of paracetamol in non-compound form. The average number of tablets taken in paracetamol overdoses decreased by 7% (0% to 12%), and the proportion involving >32 tablets decreased by 17% (4% to 28%). The average number of tablets taken in salicylate overdoses did not decrease, but 34% fewer
(2% to 56%) salicylate overdoses involved >32 tablets. After the
legislation mean blood concentrations of salicylates after overdose
decreased, as did prothrombin times; mean blood concentrations of
paracetamol did not change.
Conclusion:
Legislation restricting pack sizes of
paracetamol and salicylates in the United Kingdom has had substantial
beneficial effects on mortality and morbidity associated with self
poisoning using these drugs.
Paracetamol and salicylate overdoses are very common in the United
Kingdom and are associated with high levels of mortality and
morbidity
The number of tablets in packets of paracetamol and salicylate
preparations decreased markedly in the 12 months after the
legislation
Read all Rapid Responses